Celiac disease is characterized by malabsorption of micro and macro-nutrients in the small intestine triggered by consumption of gluten protein. Thus, leading to malnutrition and development of complications like cancers, anemia, osteoporosis and neuropathy. This study was aimed to investigate serological detection and clinical spectrum with age group dependency in celiac disease. All 999 suspected CD patients were subjected for the detection of tissue transglutaminase (tTG IgA/IgG) by ELISA. The data was measured as frequency & percentages and possible association of variables was studied by chi-square test (significant p-value < 0.05). Sero-prevalence for CD was 17.8 % with higher ratio of males age <10 (67.7%) and females age >10 (57.1%) with significance (p = 0.04). Altogether, most positive cases were presented with classical GI symptoms i.e.; abdominal pain & discomfort (94.9%), chronic diarrhea with anemia (54.4%), vomiting (19.6%), failure to thrive (83.1%). Atypical manifestations include short stature (1.6%) mild anemia (43.2%), moderate anemia (19.1%), severe anemia (3.3%), thrombocytosis (11.2%), anemia with thrombocytosis (65.1%), and anemia with Leucopenia (25.2%). Biopsy confirmed positive cases were (78%). This study is suggestive of an easier approach to identify those at higher prospect of developing celiac disease rather than biopsy. Subsequently, advancement of positive cases for biopsy could lower the attempts of needless investigations which causes significant delay and presentation of atypical features. Unsolved anemia should be screened for possible presence of CD particularly during early age of life. Furthermore, follow up data of compliance, National Awareness seminars can aid in early detection and diagnosis.